IVP at its own cost, shall secure and carry insurance, covering itself and its employees providing services under this Agreement in the minimum amount of $1 million per incident, $3 million in the aggregate, for professional negligence and general liability. Such insurance shall name IPSI and IntegraMed as additional named insureds. IVP shall also carry a policy of public liability and property damage insurance with respect to the Facilities under which the insurer agrees to indemnify IPSI and IntegraMed, subject to ordinary deductibles, against all cost, expense, and/or liability arising out of or based upon any and all claims, accidents, injuries, and damages customarily included within the coverage of such policies of insurance available for IVP. The minimum limits of liability of such insurance shall be $1 million combined single limit covering bodily injury and property damage. IPSI and IntegraMed shall be additional named insureds under the terms of such insurance coverages. A certificate of insurance evidencing such policies shall be presented to IPSI within 30 days after the execution of this Agreement. Failure to provide such certificate(s) with such period shall constitute a material breach by IVP hereunder subject to the procedures of Section 9.1.2 above.
IVP at its own cost, shall secure and carry insurance, covering itself and its employees providing services under this Agreement in the minimum amount of $1 million per incident, $3 million in the aggregate, for professional negligence and general liability. Such insurance shall name IntegraMed as an additional named insured. IVP shall also carry a policy of public liability and property damage insurance with respect to the Facilities under which the insurer agrees to indemnify IntegraMed, subject to ordinary deductibles, against all cost, expense, and/or liability arising out of or based upon any and all claims, accidents, injuries, and damages customarily included within the coverage of such policies of insurance available for IVP. The minimum limits of liability of such insurance shall be $1 million combined single limit covering bodily injury and property damage. IntegraMed shall be an additional named insured under the terms of such insurance coverages. A certificate of insurance evidencing such policies shall be presented to IntegraMed within 30 days after the execution of this Agreement. Failure to provide such certificate(s) with such period shall constitute a material breach by IVP hereunder subject to the procedures of Section 8.1.2 above.
IVP. (a) shall purchase and maintain in its inventory, sufficient Pharmaceutical Products as may be necessary from time to time to provide Pharmaceutical Services to Customers of the Medical Practices in a timely fashion; provided, however, a minimal inventory, not to exceed the dollar amount set forth on Exhibit 3.1.8 shall be maintained by IVP at all time during the Term of this Agreement; (b) shall invoice IPSI, at the Cost of Pharmaceutical Products, for such Pharmaceutical Products as are necessary to fill the orders of Customers of the Medical Practices; and (c) shall distribute such Pharmaceutical Products to Customers of the Medical Practices in accordance with all applicable laws and regulations and as prescribed by physicians associated with the Medical Practices. Cost of Pharmaceutical Products shall be paid by IPSI to IVP under the following schedule: Pharmaceutical Products shipped to Customers of Medical Practices during the first 15 days of a month shall be paid for on the 25th day of such month; Pharmaceutical Products shipped to Customers of the Medical Practice during the 16th day through the end of the month shall be paid on the 10th day of the immediately succeeding month.
IVP. (a) shall purchase for its own account at its own cost, and shall maintain in its own inventory, sufficient Pharmaceutical Products as may be necessary from time to time to satisfy IPSI'S Pharmaceutical Services in a timely fashion; (b) shall sell to IPSI, at the Cost of Pharmaceutical Products, only such Pharmaceutical Products as are necessary to fill the orders of Customers of the Medical Practices on a just-in-time basis; and (c) shall distribute such Pharmaceutical Products to Customers of the Medical Practices in accordance with all applicable laws and regulations and as prescribed by physicians associated with the Medical Practices. Cost of Pharmaceutical Products shall be paid by IPSI to IVP under the following schedule: Pharmaceutical Products sold during the first 15 days of a month shall be paid for on the 25th day of such month; Pharmaceutical Products sold during the 16th day through the end of the month shall be paid on the 10th day of the immediately succeeding month.
IVP shall arrange for the preparation of, and within 30 days following the end of each Fiscal Year shall present to IPSI, (a) a balance sheet, dated as of the last day of such Fiscal Year; (b) a cash flow statement showing the cash flows for the month and for the entire Fiscal Year then concluded; and (c) a statement showing the income and expenses of IPSI for the month and for the entire Fiscal Year then concluded. At the election of IntegraMed expressed in writing to IVP at least 90 days prior to the end of a Fiscal Year, the financial statements referred to in this Section 3.4 shall be audited by PriceWaterhouseCoopers or other independent certified public account approved by the JOB. IVP's failure to present annual financial statements to IPSI in accordance with this Section 3.4.1 within 45 days following the end of the Fiscal Year shall be deemed a material breach subject to Section 9.1.2 below.
IVP. Identifying Vulnerable People is a model that was developed in the UK and it provides practitioners with a check list of behaviors that might lead to radicalization (Xxxx et al, 2016; p. 23). The guide contains 16 indicators, five of which are considered red flag indicators (Xxxxx, 2019; p. 25). It is easy to access and to use, but some of the indicators are relevant mostly in the case of Islamist extremism (ibid. 27). One research analyzing the IVP risk assessment tool finds it reliable and argues that it is a useful tool to identify those individuals who might be at risk of becoming extremists (Xxxx et al, 2016; p. 29).
